Clinical trials in Santa Coloma De Gramenet

Ongoing research focuses on evaluating the effectiveness and safety of dazodalibep in patients with Sjögren's Syndrome, exploring its potential as a therapeutic option for managing both general symptoms and systemic manifestations of the condition.

• Primary Disease Focus: Sjögren's Syndrome
• Treatment Assessment: Long-term Safety
• Disease Severity: Moderate to Severe

These trials aim to advance treatment options for patients with varying degrees of disease severity.

Clinical investigations are underway to evaluate baxdrostat as a potential treatment for resistant hypertension, specifically targeting patients whose blood pressure remains elevated despite current standard treatments.

• Blood Pressure Management
• Treatment-Resistant Cases
• 24-hour Monitoring Assessment

The research focuses on patients who haven't achieved optimal results with conventional therapies, including multiple antihypertensive medications.

These clinical trials represent significant advances in both autoimmune and cardiovascular medicine, testing novel therapeutic approaches for conditions that often prove challenging to treat effectively with existing options.

• Novel Drug Development
• Safety Monitoring
• Treatment Efficacy Assessment

The research aims to expand treatment options for patients with complex medical conditions requiring innovative therapeutic solutions.